Adam Frederik Sander Bertelsen,Ali Salanti,Thor Theander,Susan Thrane,Christoph Mikkel Janitzek,Mette Ørskov Agerbaek,Morten Agertoug Nielsen,Jan Tobias Gustafsson
申请号：
US16691897
公开号：
US20200115420A1
申请日:
2019.11.22
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to a virus-like particle (VLP) based vaccine. The virus-like particle constitutes a non-naturally occurring, ordered and repetitive antigen array display scaffold which can obtain a strong and long-lasting immune response in a subject. The VLP-based vaccine may be used for the prophylaxis and/or treatment of a disease including, but is not limited to, cancer, cardiovascular, infectious, chronic, neurological diseases/disorders, asthma, and/or immune-inflammatory diseases/disorders.
